RT Journal Article
SR Electronic
T1 Transparency Assessment of COVID-19 Models
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.18.20156851
DO 10.1101/2020.07.18.20156851
A1 Jalali, Mohammad S.
A1 DiGennaro, Catherine
A1 Sridhar, Devi
YR 2020
UL http://medrxiv.org/content/early/2020/07/21/2020.07.18.20156851.abstract
AB As the COVID-19 pandemic has caused major societal unrest, modelers have worked to project future trends of COVID-19 and predict upcoming challenges and impacts of policy action. These models, alone or in aggregate, are influential for decision-makers at every level. Therefore, the method and documentation of COVID-19 models must be highly transparent to ensure that projections and consequential policies put forth have sound epistemological grounds. We evaluated 29 COVID-19 models receiving high attention levels within the scientific community and/or informing government responses. We evaluated these models against 27 transparency criteria. We found high levels of transparency in model documentation aspects such as reporting uncertainty analysis; however, about half of the models do not share code and a quarter do not report equations. These discrepancies underscore the need for transparency and reproducibility to be at the forefront of researchers’ priorities, especially during a global health crisis when stakes are critically high.Summary Evaluation of 29 impactful COVID-19 models reveals inconsistent adherence to best transparency practices; higher transparency is needed to inform policy.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No human involvementAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used in the assessment are reported in the supplementary document.